OncoMatch/Clinical Trials/NCT05789485

A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers

Is NCT05789485 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for gastrointestinal cancer.

Phase 2RecruitingMemorial Sloan Kettering Cancer CenterNCT05789485Data as of May 2026

The purpose of this study is to find the level of aerobic exercise (AT) that is practical, is safe, and has positive effects on the body that may reduce the side effects of therapy. The study will also look at the way the body responds to exercise and whether there are differences in treatment. This will include looking at the highest treatment dose participants receive, how many people stop, delay, or reduce the treatment, and whether additional medication is needed to treat side effects of therapy.

Check if I qualify

Extracted eligibility criteria

Cancer type

Colorectal Cancer

Gastric Cancer

Hepatocellular Carcinoma

Pancreatic Cancer

Cholangiocarcinoma

Esophageal Carcinoma

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

Hartford Healthcare Alliance (Data Collection Only) · Hartford, Connecticut
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) · Basking Ridge, New Jersey
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) · Middletown, New Jersey
Memorial Sloan Kettering Bergen (Limited Protocol Activities) · Montvale, New Jersey
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) · Commack, New York

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify